Sociedad Qu mica y Minera de Chile S.A. and GE Healthcare's Pharmaceutical Diagnostics business have announced a long-term agreement, to secure its supply of iodine, a key ingredient for contrast media products used in X-Ray and Computed Tomography (CT) procedures globally. The agreement will see SQM increase supply of iodine raw material year-on-year and is part of GE Healthcare's broader commitment and investment plan to enable the production of 30 million more patient doses of iodinated contrast media annually by 2025.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
44.38 USD | +2.01% | -1.36% | -26.31% |
Apr. 24 | Tianqi Lithium Forecasts Loss in Q1 | MT |
Apr. 24 | Tianqi Lithium Shares Dive After Warning of Wider Losses | DJ |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.31% | 12.43B | |
+11.65% | 62.84B | |
-3.47% | 45.04B | |
+13.72% | 39.67B | |
+17.83% | 25.73B | |
+7.27% | 18.27B | |
+0.06% | 17.17B | |
-21.73% | 15.81B | |
+0.22% | 14.96B | |
-18.92% | 13.51B |
- Stock Market
- Equities
- SQM Stock
- News Sociedad Química y Minera de Chile S.A.
- Sociedad Química Y Minera De Chile S.A. Announces Long-Term Agreement